High materiality7/10
DNLI price target raised to $36 from $35 at Morgan Stanley
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley raises Denali Therapeutics target to $36 from $35; current price about $23.06; priceChangeSinceSignal +1.17.
- Morgan Stanley lifts DNLI target to $36 (from $35).
Key facts
- 01
Target: $36
- 02
Posted price: $23.06
- 03
Analyst firm: Morgan Stanley
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.